Entera Bio ENTX
NASDAQ ENTX
$2.86 -0.03 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Return on Sales [ROS] (2019 - 2025)

Updated

Entera Bio's Return on Sales [ROS] was -27523.81% in Q4 2025, down 24673.81 percentage points from -2850.00% a year earlier and down 18759.29 percentage points from the prior quarter.

Analysis

Entera Bio (ENTX) Return on Sales [ROS] (2019 - 2025) Analysis & Trends

For FY2025, Return on Sales [ROS] at Entera Bio came in at -27450.00%, down 22154.42 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -24390.27 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -5295.58% in FY2024, -9714.18% in FY2022 (-7574.60 pp) and -2139.58% in FY2021 (+920.15 pp).
  • The Q4 2025 figure marks the lowest quarterly Return on Sales [ROS] since Q3 2023.
  • Compared with a year earlier, Return on Sales [ROS] has declined for three straight quarters, with an average year-over-year change of +15839.28 percentage points over the last five quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2024 (a gain of 64207.14 percentage points); the worst was Q2 2023 (a drop of 40229.55 percentage points).
  • Per Business Quant data, ENTX's Return on Sales [ROS] in the three quarters before Q4 2025 was -8764.52% (Q3 2025), -6378.92% (Q2 2025) and -6102.38% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Entera Bio 140.97 Mn 109.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -27,523.81%
Sep 30, 2025 -8,764.52%
Jun 30, 2025 -6,378.92%
Mar 31, 2025 -6,102.38%
Dec 31, 2024 -2,850.00%
Sep 30, 2024 -7,192.86%
Jun 30, 2024 -3,859.65%
Sep 30, 2023 -71,400.00%
Jun 30, 2023 -47,613.64%
Mar 31, 2023 -17,263.64%
Dec 31, 2022 -21,914.29%
Sep 30, 2022 -35,812.50%
Jun 30, 2022 -7,384.09%
Mar 31, 2022 -5,639.71%
Dec 31, 2021 -2,477.58%
Sep 30, 2021 -2,300.00%
Jun 30, 2021 -2,357.80%
Mar 31, 2021 -1,489.81%
Jun 30, 2020 -6,782.69%
Jun 30, 2019 -2,741.89%
API Access

Entera Bio Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ENTX&period=max&api_key=YOUR_API_KEY